Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry. 1991

S Bisballe, and E F Eriksen, and F Melsen, and L Mosekilde, and O H Sørensen, and I Hessov
Department of Surgery, Aarhus C, Denmark.

The prevalence of metabolic disease in a population of 68 postgastrectomy patients was assessed using histomorphometric evaluation of transiliac bone biopsy specimens after tetracycline double labelling. Trabecular bone volume was significantly lower in the postgastrectomy group (p less than 0.01): 62% of the patients had increased osteoid surface, 56% increased osteoid thickness, and 24% increased mineralisation lag time. Only 18%, however, fulfilled the diagnostic criteria for osteomalacia--increased osteoid thickness and increased mineralisation lag time. Postgastrectomy patients had reduced serum concentrations of calcium (p less than 0.01), phosphate (p less than 0.01), and 25-hydroxyvitamin D, while levels of alkaline phosphatase and 1,25 dihydroxyvitamin D were high (p less than 0.01). The severity of the mineralisation defect as reflected by mineralisation lag time was positively correlated to serum 25-hydroxyvitamin D, but unrelated to serum 1,25-dihydroxyvitamin D. Multiple linear regression analysis showed that serum 25-hydroxyvitamin D, age, and the duration of postoperative follow up were significant determinants of the mineralisation defect in a given patient. The limited value of serum markers in the diagnosis of osteomalacia was emphasised by the fact that six of the eight patients with osteomalacia had normal serum levels of calcium and alkaline phosphatase, and five of the eight had values for 25-hydroxyvitamin D in the normal range for healthy control subjects. The results clearly show the need for vitamin D supplementation and regular control after gastric resection.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010018 Osteomalacia Disorder caused by an interruption of the mineralization of organic bone matrix leading to bone softening, bone pain, and weakness. It is the adult form of rickets resulting from disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis. Adult Rickets,Rickets, Adult
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D001851 Bone Diseases, Metabolic Diseases that affect the METABOLIC PROCESSES of BONE TISSUE. Low Bone Density,Low Bone Mineral Density,Osteopenia,Metabolic Bone Diseases,Bone Density, Low,Bone Disease, Metabolic,Low Bone Densities,Metabolic Bone Disease,Osteopenias
D005260 Female Females
D005743 Gastrectomy Excision of the whole (total gastrectomy) or part (subtotal gastrectomy, partial gastrectomy, gastric resection) of the stomach. (Dorland, 28th ed) Gastrectomies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

S Bisballe, and E F Eriksen, and F Melsen, and L Mosekilde, and O H Sørensen, and I Hessov
January 1982, Metabolic bone disease & related research,
S Bisballe, and E F Eriksen, and F Melsen, and L Mosekilde, and O H Sørensen, and I Hessov
October 1984, The American journal of medicine,
S Bisballe, and E F Eriksen, and F Melsen, and L Mosekilde, and O H Sørensen, and I Hessov
January 1986, Advances in experimental medicine and biology,
S Bisballe, and E F Eriksen, and F Melsen, and L Mosekilde, and O H Sørensen, and I Hessov
March 2018, The Journal of steroid biochemistry and molecular biology,
S Bisballe, and E F Eriksen, and F Melsen, and L Mosekilde, and O H Sørensen, and I Hessov
February 1987, The American journal of medicine,
S Bisballe, and E F Eriksen, and F Melsen, and L Mosekilde, and O H Sørensen, and I Hessov
February 1982, Metabolism: clinical and experimental,
S Bisballe, and E F Eriksen, and F Melsen, and L Mosekilde, and O H Sørensen, and I Hessov
January 2018, Clinical calcium,
S Bisballe, and E F Eriksen, and F Melsen, and L Mosekilde, and O H Sørensen, and I Hessov
November 1965, Lancet (London, England),
S Bisballe, and E F Eriksen, and F Melsen, and L Mosekilde, and O H Sørensen, and I Hessov
January 1977, Acta medica Scandinavica,
S Bisballe, and E F Eriksen, and F Melsen, and L Mosekilde, and O H Sørensen, and I Hessov
August 1984, Gastroenterology,
Copied contents to your clipboard!